BRST Trademark

Trademark Overview

On Friday, February 8, 2019, a trademark application was filed for BRST with the United States Patent and Trademark Office. The USPTO has given the BRST trademark a serial number of 88294940. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2020. This trademark is owned by Andorra Pharmaceuticals, LLC. The BRST trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable matrices that facilitate delivery of a wide range of pharmaceuticals
brst

General Information

Serial Number88294940
Word MarkBRST
Filing DateFriday, February 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable matrices that facilitate delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAndorra Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOcala, FL 34476
Party NameAndorra Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOcala, FL 34476

Trademark Events

Event DateEvent Description
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 21, 2020EXTENSION 1 GRANTED
Tuesday, May 12, 2020EXTENSION 1 FILED
Friday, August 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 9, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, July 9, 2020EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 9, 2020PETITION TO REVIVE-GRANTED
Thursday, July 9, 2020TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 15, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 15, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 5, 2019ASSIGNED TO LIE
Tuesday, July 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 25, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, April 25, 2019PRIORITY ACTION E-MAILED
Thursday, April 25, 2019PRIORITY ACTION WRITTEN
Monday, April 22, 2019ASSIGNED TO EXAMINER
Monday, March 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 15, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 12, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

brst delivery wide range pharmaceuticals drug facilitate agents dissolvable form compounds